Diabetes Kongress 2019
zur Liste
Prof. Stefan Anker
Universitätsmedizin Berlin Germany
  • Vortrag Design and rationale of the EMPEROR trials of, empagliflozin 10 mg once daily, in patients with chronic heart failure with reduced ejection fraction (EMPEROR-Reduced) or preserved ejection fraction (EMPEROR-Preserved) Speaker
    Datum: 31.05.2019 , Zeit: 11:30 | Thema: 03. Grundlagenforschung Typ-1-Diabetes/ Betazelle/ Typ-1-Diabetes/ Adipositas/ Fettgewebe
    Details